Christopher Michel Kearney

This paper develops a bioengineered probiotic expressing guided antimicrobial peptides to selectively target Fusobacterium nucleatum in colorectal cancer, showing reduced toxicity to non-target bacteria and preserved gut microbiota diversity.

This paper demonstrates the use of bioengineered probiotics releasing guided antimicrobial peptides to selectively kill H. pylori in mice without disrupting the stomach microbiome.

The paper demonstrates that bioengineered L. lactis releasing guided antimicrobial peptides can selectively inhibit H. pylori in vitro without affecting other bacteria.

The paper fuses bacteriophage-derived targeting peptides to antimicrobial peptides to selectively kill Staphylococcus bacteria, showing reduced toxicity against non-target species.

This study introduces a modified N-Gram and Skip-Gram model for protein classification from primary sequence data, showing improved accuracy over existing methods.